当前位置:首页 - 行情中心 - 泽璟制药-U(688266) - 财务分析

泽璟制药-U

(688266)

  

流通市值:283.24亿  总市值:283.24亿
流通股本:2.65亿   总股本:2.65亿

泽璟制药-U(688266)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润6.33亿元,每股收益2.39元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益171305.45万元,未分配利润-164707.61万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产368838.61万元,负债197533.17万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入905,391,322.84810,484,651.18593,440,129.02375,650,273.55
营业总成本272,317,383.641,025,913,989.8720,231,851.57475,168,324.66
其他经营收益
营业利润632,287,204.83-168,013,241.88-96,762,629.52-76,731,169.28
利润总额631,770,599.4-168,654,782.77-98,319,633.96-77,414,988.02
净利润632,612,572.5-165,126,809.51-95,596,820.94-75,569,945.5
每股收益
其他综合收益-6,314.96366,110.72-598,227.97-477,198.95
综合收益总额632,606,257.54-164,760,698.79-96,195,048.91-76,047,144.45
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计3,158,916,488.272,443,104,161.92,505,923,345.632,551,629,069.4
非流动资产:
非流动资产合计529,469,658.6526,081,429507,454,092.73447,574,282.64
资产总计3,688,386,146.872,969,185,590.93,013,377,438.362,999,203,352.04
流动负债:
流动负债合计1,338,521,484.911,427,939,874.321,354,855,501.351,342,223,646.4
非流动负债:
非流动负债合计636,810,178.42460,797,490.58509,508,061.13480,364,269.2
负债合计1,975,331,663.331,888,737,364.91,864,363,562.481,822,587,915.6
所有者权益(或股东权益):
归属于母公司股东权益合计1,713,054,483.541,080,448,2261,149,013,875.881,176,615,436.44
股东权益合计1,713,054,483.541,080,448,2261,149,013,875.881,176,615,436.44
负债和股东权益合计3,688,386,146.872,969,185,590.93,013,377,438.362,999,203,352.04
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,144,731,089.331,055,481,598.12766,141,565.65475,143,193.87
经营活动现金流出小计307,316,593.211,084,263,584.36782,875,487.51492,163,469.95
经营活动产生的现金流量净额837,414,496.12-28,781,986.24-16,733,921.86-17,020,276.08
投资活动产生的现金流量:
投资活动现金流入小计428,238,736.11125,832,291.3465,943,533.3317,373,200
投资活动现金流出小计1,033,253,949.86181,466,703.44132,497,229.0679,715,800.36
投资活动产生的现金流量净额-605,015,213.75-55,634,412.1-66,553,695.73-62,342,600.36
筹资活动产生的现金流量:
筹资活动现金流入小计56,000,0001,126,882,468.69616,021,145.08431,521,145.08
筹资活动现金流出小计213,981,663.741,134,383,480.86616,706,142405,608,309.59
筹资活动产生的现金流量净额-157,981,663.74-7,501,012.17-684,996.9225,912,835.49
汇率变动对现金及现金等价物的影响-4,503,785.11-690,409.18-527,602.39-453,654.23
现金及现金等价物净增加额69,913,833.52-92,607,819.69-84,500,216.9-53,903,695.18
期末现金及现金等价物余额194,571,506.91124,657,673.39132,765,276.18163,361,797.9
补充资料:
现金及现金等价物的净增加额--92,607,819.69--53,903,695.18
最新报告期:2026-04-20
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
兴业证券孙媛媛,杨希成,郭沛骅,黄翰漾2.181.251.802026-04-20
野村东方国际证券孔令岩,肖鸿德2.161.752.522026-04-17
中信建投沈毅,赵旭,袁清慧,贺菊颖2.440.021.122026-04-05
国投证券连国强2.511.672.922026-03-31
东吴证券苏丰,朱国广2.042.433.632026-03-30
TOP↑